Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Sciformix Awarded Best Safety & Risk Management Company

Published: Monday, August 22, 2016
Last Updated: Monday, August 22, 2016
Bookmark and Share
Sciformix Corporation has been recognized as the Best Safety & Risk Management Company in the 2016 International Life Sciences Awards.

Sciformix Corporation has been recognized as the Best Safety & Risk Management Company in the 2016 International Life Sciences Awards. Sciformix was selected by a panel of experts based on select criteria for outstanding performance in areas such as customer and client reviews, services offered, previous accolades and overall company performance.

The 2016 International Life Sciences Awards, an initiative of Global Health and Pharma (GHP), celebrates the unique contributions of the life science industry and gives recognition to outstanding organizations that help to advance the field. The industry continues to bring innovative products that impact human health on a global basis in areas that cover complex and challenging medical conditions and healthcare needs. The need for strong domain expertise for these endeavors has created unprecedented opportunities for outsourcing activities to specialty providers, like SPOs, who contribute with their foundation of rich scientific expertise and optimized processes in areas such as drug safety, regulatory affairs and clinical operations.

Sciformix was selected for the award based on a case file built by GHP’s judging and research teams. This acknowledgment demonstrates how Sciformix provides “best in class” scientific services spanning the entire product life cycle from pre-clinical to post-marketing activities. Sciformix’s global and flexible service model is customized for each client’s unique needs and can be implemented seamlessly through a thoroughly mapped and automated process, built on an integrated technology platform.

The lead awards researcher for the case explained “We looked at a number of different areas when choosing Sciformix for their award. We were very impressed with their integrated approach towards drug safety.  Their continued success, such as branching into the UK last year and having a total of 1,000 employees globally was another factor that we took into consideration. Blog posts and presence at industry events also highlighted how they were continually up to speed with latest trends and developments in the life sciences sector. And of course, the other awards and recognition by other third parties was also a good indicator when making our decision.”

On the announcement of the recognition, President and CEO of Sciformix, Manish Soman, commented “We are deeply honored to be recognized as Best Life Sciences Safety & Risk Management Company, and humbled to be in the company of such innovative and accomplished solution providers.”  He added, “Safety and Risk Management is a core area of the company’s business strategy. We maintain high quality safety data, scalability and predictability by employing optimized and efficient processes, robust metrics and state of the art technology in light of the ever increasing regulatory requirements.”

Sciformix, headquartered in the US, with operations in the UK, India and Philippines, partners with life science clients to provide a full range of services from study design to post-marketing surveillance. Areas of specialization include Safety and Risk Management, Clinical Research and Post Approval Support, Medical Affairs, Scientific Writing, Regulatory Affairs and Technology services.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sciformix Introduces New Technology Services Offering
Company recognizes crucial need in the market for scientific IT providers.
Wednesday, May 18, 2016
Sciformix CEO Recognized as Most Talented Leader in Outsourcing
Sciformix is pleased to announce that Manish Vinayak Soman, President and CEO of Sciformix, has been named as one of the ‘Most Talented Leaders in the Outsourcing Industry’.
Tuesday, February 23, 2016
Sciformix Opens New Office in Manila
Company continues expansion with opening of new office to accommodate rapid growth.
Monday, August 12, 2013
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Epigenetics and Neural Cell Death
Researchers demonstrate how deregulation of an epigenetic mechanism active in early neurogenesis phases triggers neural cell death.
Ebola-Affected Countries Receive NIH Support
The National Institutes of Health has established a new program to further research capacity to study Ebola and other epidemics.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Skin Patch to Treat Peanut Allergy
NIH-funded study suggests peanut protein patch is a safe and convenient method of treatment.
Molecular Origins of Dust Mite Allergy Discovered
Scientists have identified molecules of house dust mites that are targeted by the immune system of children, developing allergic rhinitis and asthma.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos